Synapse - Mark Awad

Search Within

Mark Awad

Results (3)

Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with resectable NSCLC: Updated survival and biomarker analyses from CheckMate 77T

Meeting Abstract

Cascone, T.; Awad, M. M.; Spicer, J.; He, J.; Lu, S.; Tanaka, F.; Cornelissen, R.; Petruzelka, L. B.; Ito, H.; De Oliveira Koch, L.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Overall survival with neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) in patients with resectable NSCLC in CheckMate 816

Meeting Abstract

Forde, P. M.; Spicer, J.; Provencio, M.; Mitsudomi, T.; Awad, M. M.; Wang, C.; Lu, S.; Felip, E.; Broderick, S.; Swanson, S.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Gene copy deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic features and association with the outcomes of immunotherapy with or without chemotherapy in nonsquamous NSCLC

Journal Article

Gandhi, M. M.; Elkrief, A.; Moore, C. G.; Ricciuti, B.; Alessi, J. V.; Richards, A. L.; Tischfield, S.; Williams, J.; Lamberti, G.; Pecci, F.; more...
Journal of Thoracic Oncology (2025)

Fulltext@MSK | Save